Preferred Name

Disulfiram
Synonyms
Definitions

An orally bioavailable carbamoyl derivative and a proteasome inhibitor that is used in the treatment of alcoholism, with potential antineoplastic and chemosensitizing activities. Disulfiram (DSF) may help to treat alcoholism by irreversibly binding to and inhibiting acetaldehyde dehydrogenase, an enzyme that oxidizes the ethanol metabolite acetaldehyde into acetic acid. Inhibition of acetaldehyde dehydrogenase leads to an accumulation of acetaldehyde and produces a variety of very unpleasant symptoms, which together are referred to as the disulfiram-ethanol reaction (DER). In addition, DSF has a strong ability to chelate metals and its antineoplastic activity is highly dependent upon binding to copper (Cu), a metal that selectively accumulates in cancer cells. DSF/Cu generates reactive oxygen species (ROS) and inhibits proteasome activity, leading to an accumulation of ubiquitinated proteins; both of these processes result in induction of apoptosis. Also, DSF/Cu inhibits various cancer-specific pathways, which leads to inhibition of tumor cell growth.

ID

http://purl.obolibrary.org/obo/NCIT_C447

ALT_DEFINITION

A drug that slows the metabolism of retinoids, allowing them to act over a longer period of time.

CAS_Registry

97-77-8

CHEBI_ID

CHEBI:4659

Chemical_Formula

C10H20N2S4

code

C447

Contributing_Source

CTRP

FDA

definition

An orally bioavailable carbamoyl derivative and a proteasome inhibitor that is used in the treatment of alcoholism, with potential antineoplastic and chemosensitizing activities. Disulfiram (DSF) may help to treat alcoholism by irreversibly binding to and inhibiting acetaldehyde dehydrogenase, an enzyme that oxidizes the ethanol metabolite acetaldehyde into acetic acid. Inhibition of acetaldehyde dehydrogenase leads to an accumulation of acetaldehyde and produces a variety of very unpleasant symptoms, which together are referred to as the disulfiram-ethanol reaction (DER). In addition, DSF has a strong ability to chelate metals and its antineoplastic activity is highly dependent upon binding to copper (Cu), a metal that selectively accumulates in cancer cells. DSF/Cu generates reactive oxygen species (ROS) and inhibits proteasome activity, leading to an accumulation of ubiquitinated proteins; both of these processes result in induction of apoptosis. Also, DSF/Cu inhibits various cancer-specific pathways, which leads to inhibition of tumor cell growth.

Display_Name

Disulfiram

FDA_UNII_Code

TR3MLJ1UAI

Has_Target

http://purl.obolibrary.org/obo/NCIT_C13314

in_subset

http://purl.obolibrary.org/obo/NCIT_C63923

http://purl.obolibrary.org/obo/NCIT_C173383

http://purl.obolibrary.org/obo/NCIT_C173381

http://purl.obolibrary.org/obo/NCIT_C176424

http://purl.obolibrary.org/obo/NCIT_C116977

http://purl.obolibrary.org/obo/NCIT_C116978

label

Disulfiram

Legacy Concept Name

Disulfiram

NCI_Drug_Dictionary_ID

42291

NSC Number

25953

PDQ_Closed_Trial_Search_ID

42291

PDQ_Open_Trial_Search_ID

42291

Preferred_Name

Disulfiram

prefixIRI

NCIT:C447

prefLabel

Disulfiram

Semantic_Type

Organic Chemical

Pharmacologic Substance

UMLS_CUI

C0012772

subClassOf

http://purl.obolibrary.org/obo/NCIT_C2160

http://purl.obolibrary.org/obo/NCIT_C1742

http://purl.obolibrary.org/obo/NCIT_C1744

Delete Subject Author Type Created
No notes to display
Create mapping

Mapping To Ontology Source
http://purl.obolibrary.org/obo/CHEBI_4659 DRON LOOM
http://purl.jp/bio/4/id/200906089580597545 IOBC LOOM
https://go.drugbank.com/drugs/DB00822 MDM LOOM
http://purl.bioontology.org/ontology/SNOMEDCT/387212009 SNOMEDCT LOOM
http://purl.bioontology.org/ontology/MESH/D004221 MESH LOOM
http://purl.bioontology.org/ontology/LNC/LP16119-7 LOINC LOOM
http://purl.obolibrary.org/obo/dinto_DB00822 DINTO LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#D02.241.081.251.869.220.250 RH-MESH LOOM
http://purl.bioontology.org/ontology/NDDF/000752 NDDF LOOM
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C447 NCIT LOOM
http://purl.bioontology.org/ontology/SNMI/C-B70A0 SNMI LOOM
http://purl.bioontology.org/ontology/NDFRT/N0000146816 NDFRT LOOM
http://purl.bioontology.org/ontology/VANDF/4018494 VANDF LOOM
http://purl.bioontology.org/ontology/RXNORM/3554 RXNORM LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#C0012772 OCHV LOOM
http://stirdf.jst.go.jp/id/200907076711602786 IOBC LOOM
http://purl.bioontology.org/ontology/CSP/2903-9805 CRISP LOOM
http://purl.obolibrary.org/obo/OMIT_0005482 OMIT LOOM
http://purl.bioontology.org/ontology/ATC/N07BB01 ATC LOOM
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Disulfiram APAONTO LOOM
http://www.drugbank.ca/drugs/DB00822 FTC LOOM
http://www.phoc.org.cn/pmo/class/PMO_00016352 PMAPP-PMO LOOM
http://www.co-ode.org/ontologies/galen#Disulfiram GALEN LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#D02.886.706.200.200 RH-MESH LOOM
http://purl.obolibrary.org/obo/CHEBI_4659 PDRO LOOM
http://purl.obolibrary.org/obo/CHEBI_4659 FIDEO LOOM
http://purl.obolibrary.org/obo/CHEBI_4659 CCONT LOOM
http://purl.obolibrary.org/obo/CHEBI_4659 HOIP LOOM
http://purl.obolibrary.org/obo/CHEBI_4659 CHEBI LOOM
http://purl.obolibrary.org/obo/CHEBI_4659 COVID-19 LOOM
http://purl.obolibrary.org/obo/CHEBI_4659 DDSS LOOM
http://purl.obolibrary.org/obo/CHEBI_4659 TXPO LOOM
http://purl.obolibrary.org/obo/CHEBI_4659 BIOMODELS LOOM
http://purl.obolibrary.org/obo/CHEBI_4659 NIFSTD LOOM
http://purl.obolibrary.org/obo/CHEBI_4659 ECTO LOOM
http://purl.obolibrary.org/obo/CHEBI_4659 EFO LOOM
http://purl.obolibrary.org/obo/CHEBI_4659 ODNAE LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#4042 OCHV LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#D02.886.520.150.175 RH-MESH LOOM
http://purl.bioontology.org/ontology/LNC/MTHU006972 LOINC LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#D004221 RH-MESH LOOM
http://purl.bioontology.org/ontology/ATC/P03AA04 ATC LOOM
http://doe-generated-ontology.com/OntoAD#C0012772 ONTOAD LOOM
http://purl.bioontology.org/ontology/PDQ/CDR0000042291 PDQ LOOM